Astrazeneca Pharmaceuticals Lp drugs

34 results
  • bevespi aerosphere - glycopyrrolate and formoterol fumarate aerosol, metered

    (Glycopyrrolate And Formoterol Fumarate)
    Astrazeneca Pharmaceuticals Lp
    Bevespi Aerosphere is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not for relief of acute bronchospasm or for treating asthma.
  • brilinta - ticagrelor tablet

    (Ticagrelor)
    Astrazeneca Pharmaceuticals Lp
    Brilinta reduces the risk of cardiovascular death, heart attack, and stroke in patients with acute coronary syndrome or prior heart attack. It also lowers the risk of first heart attack or stroke in high-risk coronary artery disease patients, and reduces stroke risk after mild ischemic stroke or high-risk TIA.
  • calquence - acalabrutinib tablet, film coated

    (Acalabrutinib)
    Astrazeneca Pharmaceuticals Lp
    CALQUENCE treats adults with mantle cell lymphoma (MCL) — either previously untreated (with bendamustine and rituximab, when ineligible for stem cell transplant) or after prior therapy — and adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • crestor - rosuvastatin tablet, film coated

    (Rosuvastatin)
    Astrazeneca Pharmaceuticals Lp
    Crestor lowers LDL cholesterol and reduces major cardiovascular event risk in high-risk adults. Also indicated for primary hyperlipidemia, slowing atherosclerosis, familial hypercholesterolemia (HeFH in adults/children ≥8; HoFH in adults/children ≥7), primary dysbetalipoproteinemia, and hypertriglyceridemia.